| Date Filed | Type | Description |
| 08/11/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 08/04/2023 |
4
| Fluegel Bradley M (Director) has filed a Form 4 on NeuroMetrix, Inc.|
Txns:
| Granted 43,165 restricted stock units
@ $1.39, valued at
$60k
|
|
| 08/04/2023 |
4
| Goodman David (Director) has filed a Form 4 on NeuroMetrix, Inc.|
Txns:
| Granted 43,165 restricted stock units
@ $1.39, valued at
$60k
|
|
| 08/04/2023 |
4
| KATZ NANCY E (Director) has filed a Form 4 on NeuroMetrix, Inc.|
Txns:
| Granted 43,165 restricted stock units
@ $1.39, valued at
$60k
|
|
| 08/04/2023 |
4
| Van Avermaete David (Director) has filed a Form 4 on NeuroMetrix, Inc.|
Txns:
| Granted 43,165 restricted stock units
@ $1.39, valued at
$60k
|
|
| 08/04/2023 |
4
| HIGGINS THOMAS T (Senior Vice President, CFO) has filed a Form 4 on NeuroMetrix, Inc.|
Txns:
| Paid exercise price by delivering 584 shares
@ $0.8701, valued at
$508.1
Exercised 3,983 restricted stock units
@ $0.8701, valued at
$3.5k
|
|
| 08/04/2023 |
4
| Gozani Shai (President & CEO) has filed a Form 4 on NeuroMetrix, Inc.|
Txns:
| Paid exercise price by delivering 369 shares
@ $0.8701, valued at
$321.1
Exercised 5,086 restricted stock units
@ $0.8701, valued at
$4.4k
|
|
| 07/27/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 07/27/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/27/2023 |
8-K
| Quarterly results |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/05/2023 |
4
| Goodman David (Director) has filed a Form 4 on NeuroMetrix, Inc.|
Txns:
| Exercised 17,647 restricted stock units
@ $1.39, valued at
$24.5k
|
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
8-K
| Quarterly results |
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/03/2023 |
8-K
| Quarterly results |
| 03/22/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex... |
| 02/23/2023 |
8-K
| Quarterly results |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/20/2022 |
8-K
| Quarterly results |
| 08/31/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 07/21/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/21/2022 |
8-K
| Quarterly results |
| 07/06/2022 |
4
| Fluegel Bradley M (Director) has filed a Form 4 on NeuroMetrix, Inc.|
Txns:
| Granted 27,472 shares
@ $0 |
|
| 07/06/2022 |
3
| Fluegel Bradley M (Director) has filed a Form 3 on NeuroMetrix, Inc. |
| 06/28/2022 |
8-K
| Quarterly results |
|